Results 121 to 130 of about 2,165 (170)

ERG and VECP in chronic progressive external ophthalmoplegia (CPEO)

open access: closedDocumenta Ophthalmologica, 1985
Eleven patients suffering from chronic progressive external ophthalmoplegia (CPEO) were investigated by means of electroretinograms (ERG) and visually evoked cortical potentials (VECP) to flash and checkerboard-reversal stimuli. One patient exhibited a Kearns syndrome, in two patients fundoscopy revealed pigmentary retinopathy, and the other eight ...
H. Berdjis, Wolfgang Heider, K. Demisch
openalex   +3 more sources

[Multiple mitochondrial DNA deletions in chronic progressive external ophthalmoplegia (CPEO)].

open access: closedNihon rinsho. Japanese journal of clinical medicine, 1993
We reviewed familial cases of chronic progressive external ophthalmoplegia (CPEO) associated with multiple mitochondrial DNA (mtDNA) deletions. A new case of familial CPEO with multiple mtDNA deletions, which were detected in the proband's skeletal muscles by Southern blotting and in all the tissues examined by using the polymerase chain reaction is ...
Shingo Kawashima, Masatoyo Nishizawa
openalex   +2 more sources

CPEO and KSS differ in the percentage and location of the mtDNA deletion

open access: closedMitochondrion, 2009
Disorders caused by single mtDNA deletions are quite rare in the general population. To understand the molecular mechanism by which they come about and try to correlate the type of deletion with the phenotype of the patients, a very large cohort of affected individuals needs to be studied.
Ester López‐Gallardo   +3 more
openalex   +3 more sources

Chronic Progressive External Ophthalmoplegia (CPEO)

open access: closed, 2023
Gabriele Berman   +2 more
openalex   +2 more sources

Reversible ophthalmoplegia in CPEO

Australian and New Zealand Journal of Ophthalmology, 1995
Abstract Purpose: To present a case of improvement of ocular motility in a patient with chronic progressive external ophthalmoplegia (CPEO) with Coenzyme Q10. Methods: Coenzyme Q10 300 mg daily was given for three years with a three‐day trial period of 200 mg daily after one year. Ocular ductions were measured by synoptophore.
I S, Dunlop, P, Dunlop
openaire   +2 more sources

CPEO and carnitine deficiency overlapping in MELAS syndrome

Acta Neurologica Scandinavica, 2009
Mitochondrial myopathy, encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome is one of the mitochondrial encephalomyopathies that has distinct clinical features including stroke-like episodes with migraine-like headache, nausea, vomiting, encephalopathy and lactic acidosis.
C.-C. Hsu   +10 more
openaire   +2 more sources

Extra-Ocular Muscle Limitation in Chronic Progressive External Ophthalmoplegia (CPEO)

2021
We wanted to assess the extent and pattern of ophthalmoplegia, by a quantitative and reproducible method. We also wanted to identify whether any correlation existed between the amount of ophthalmoplegia and the percentage of mitochondrial DNA deletion.
Teresa Smith   +3 more
openaire   +1 more source

155 MORPHOLOGICAL AND BIOCHEMICAL ANALYSIS IN CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA (CPEO)

open access: closedJournal of Neuropathology and Experimental Neurology, 1981
Raffaello Nemni   +4 more
openalex   +2 more sources

SANDO-Syndrom bei Patienten mit CPEO und multiplen Deletionen der mtDNA

open access: closedAktuelle Neurologie, 2005
Marcus Deschauer   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy